FRAME-001 Personalized Vaccine in NSCLC

Clinical trial NCT04998474 · UNKNOWN

Trial details

NCT number: NCT04998474
Sponsor: Frame Pharmaceuticals B.V.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2022-01-01
Primary completion: 2024-01-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.